Modulating sensory perceptions during psychedelic induced therapy
AssigneeMedda, Inc.
InventorsCaleb McClain, Jeffrey Humpherys, Mounir Bendahmane
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedda, Inc.
InventorsCaleb McClain, Jeffrey Humpherys, Mounir Bendahmane
Estimating the term…
The present invention extends to methods, systems, and computer program products for modulating sensory perceptions during psychedelic induced therapy. Remote distributed virtual environments can be created enabling virtual group psychedelic therapy. Visual, auditory, and olfactory devices can be used to alter a patients' baseline sensory perceptions and obfuscate or limit knowledge about whether a patient was in the treatment or control group within placebo-controlled clinical trials. Various mechanisms are used to administer psychedelic drugs to a patient and accumulate psychedelic drugs in specific areas of the brain. Virtual environments can be tailored and specific brain wave states induced enabling targeted therapeutic outcomes in psychedelic therapy.
A method comprising:
A method comprising:
Dependencies are inferred from the claim text.